LBPH – longboard pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $60.00 price target on the stock.
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its price target raised by analysts at Wedbush from $32.00 to $34.00. They now have an "outperform" rating on the stock.
Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates [Yahoo! Finance]
Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $36.00 price target on the stock.
Form 10-Q Longboard Pharmaceutical For: Mar 31
Form 8-K Longboard Pharmaceutical For: May 02
Form 8-K Longboard Pharmaceutical For: Apr 15
Form ARS Longboard Pharmaceutical For: Dec 31
Form DEFA14A Longboard Pharmaceutical
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.